Differences in initial treatment patterns and outcomes of lung cancer in the elderly

Background: Non-small cell lung cancer (NSCLC) accounts for substantial deaths and costs in the elderly greater than 65 years old. The current practice of NSCLC treatment in a Medicare population was examined to ascertain important areas of practice variation, and differences in clinical outcome and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lung cancer (Amsterdam, Netherlands) Netherlands), 1995-12, Vol.13 (3), p.235-252
Hauptverfasser: Smith, Thomas J., Penberthy, Lynne, Desch, Christopher E., Whittemore, Martha, Newschaffer, Craig, Hillner, Bruce E., McClish, Donna, Retchin, Sheldon M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 252
container_issue 3
container_start_page 235
container_title Lung cancer (Amsterdam, Netherlands)
container_volume 13
creator Smith, Thomas J.
Penberthy, Lynne
Desch, Christopher E.
Whittemore, Martha
Newschaffer, Craig
Hillner, Bruce E.
McClish, Donna
Retchin, Sheldon M.
description Background: Non-small cell lung cancer (NSCLC) accounts for substantial deaths and costs in the elderly greater than 65 years old. The current practice of NSCLC treatment in a Medicare population was examined to ascertain important areas of practice variation, and differences in clinical outcome and costs. Methods: Data from incident cases of NSCLC from the Virginia Cancer Registry (VCR), 1985–1989, were matched with claims from Medicare Part A and B, census tract data and the Area Resource File. Multivariate models were created to include clinical data, demographics, and access information. Results: For patients with locoregional disease, increasing age was associated with lower likelihood of therapy (odds ratio (OR) 0.35; confidence intervals (CI) 0.29,0.43), thoracotomy (OR 0.27; CI 0.21,0.34), and more use of radiation therapy compared to surgery (OR 1.69; CI 1.39,2.03). Low education levels were associated with less likelihood of treatment (OR 0.78; CI 0.66,0.94), or radiation instead of surgery (OR 1.22; CI 1.05,1.47). Patients in urban areas were less likely to receive therapy (OR 0.67; CI 0.49,0.92). For distant disease, increasing age was also associated with lower likelihood of treatment (OR 0.48; CI 0.41,0.56), as was increasing co-morbidity (OR 0.84; CI 0.75,0.93). Distance to radiation oncologists made no difference in radiotherapy utilization. Two year survival according to therapy was surgery 66%, radiation 15%, no therapy 17%. Conclusions: Patterns of care, and survival according to therapy, vary widely for elderly NSCLC patients. Age, low education, higher co-morbidity and urban residence all decrease the likelihood of surgical therapy for locoregional NSCLC. Despite the availability of coverage through the Medicare program, use of therapies and survival is not uniform for all beneficiaries. Possible discrimination by age, co-morbid illnesses not recorded in the Medicare files, or patient and provider choice could all be involved; administrative billing files cannot resolve these important differences.
doi_str_mv 10.1016/0169-5002(95)00496-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77880898</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0169500295004963</els_id><sourcerecordid>77880898</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-988e0449c6d20c04b0fd180fde1e53ec6991c13771c1f511a8b4e836a7beefb03</originalsourceid><addsrcrecordid>eNp9kE1P3DAQhi1UtCxb_gFIOaCKHkLHcRLbF6QK2oKExGU5W44zpq7ysdgOEv8eh432WGlmfJjnHVkPIecUrinQ-kdqmVcAxZWsvgOUss7ZEVlTwYtcMFZ8IesDckJOQ_gHQDkFuSIrwamEulyT7Z2zFj0OBkPmhlQuOt1l0aOOPQ4x2-kY0Q8h00ObjVM0Y5_Q0WbdNLxkRqekn5PxL2bYtei796_k2Oou4Nnybsjz71_b2_v88enPw-3Px9wwUcdcCoFQltLUbQEGygZsS0UaSLFiaGopqaGM8zRtRakWTYmC1Zo3iLYBtiHf9nd3fnydMETVu2Cw6_SA4xQU50KAkCKB5R40fgzBo1U773rt3xUFNctUsyk1m1KyUp8yFUuxi-X-1PTYHkKLvbS_XPY6GN1Zn2S4cMAKWXJJecJu9hgmF28OvQrGzcZb59FE1Y7u___4AAjvkGE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77880898</pqid></control><display><type>article</type><title>Differences in initial treatment patterns and outcomes of lung cancer in the elderly</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Smith, Thomas J. ; Penberthy, Lynne ; Desch, Christopher E. ; Whittemore, Martha ; Newschaffer, Craig ; Hillner, Bruce E. ; McClish, Donna ; Retchin, Sheldon M.</creator><creatorcontrib>Smith, Thomas J. ; Penberthy, Lynne ; Desch, Christopher E. ; Whittemore, Martha ; Newschaffer, Craig ; Hillner, Bruce E. ; McClish, Donna ; Retchin, Sheldon M.</creatorcontrib><description>Background: Non-small cell lung cancer (NSCLC) accounts for substantial deaths and costs in the elderly greater than 65 years old. The current practice of NSCLC treatment in a Medicare population was examined to ascertain important areas of practice variation, and differences in clinical outcome and costs. Methods: Data from incident cases of NSCLC from the Virginia Cancer Registry (VCR), 1985–1989, were matched with claims from Medicare Part A and B, census tract data and the Area Resource File. Multivariate models were created to include clinical data, demographics, and access information. Results: For patients with locoregional disease, increasing age was associated with lower likelihood of therapy (odds ratio (OR) 0.35; confidence intervals (CI) 0.29,0.43), thoracotomy (OR 0.27; CI 0.21,0.34), and more use of radiation therapy compared to surgery (OR 1.69; CI 1.39,2.03). Low education levels were associated with less likelihood of treatment (OR 0.78; CI 0.66,0.94), or radiation instead of surgery (OR 1.22; CI 1.05,1.47). Patients in urban areas were less likely to receive therapy (OR 0.67; CI 0.49,0.92). For distant disease, increasing age was also associated with lower likelihood of treatment (OR 0.48; CI 0.41,0.56), as was increasing co-morbidity (OR 0.84; CI 0.75,0.93). Distance to radiation oncologists made no difference in radiotherapy utilization. Two year survival according to therapy was surgery 66%, radiation 15%, no therapy 17%. Conclusions: Patterns of care, and survival according to therapy, vary widely for elderly NSCLC patients. Age, low education, higher co-morbidity and urban residence all decrease the likelihood of surgical therapy for locoregional NSCLC. Despite the availability of coverage through the Medicare program, use of therapies and survival is not uniform for all beneficiaries. Possible discrimination by age, co-morbid illnesses not recorded in the Medicare files, or patient and provider choice could all be involved; administrative billing files cannot resolve these important differences.</description><identifier>ISSN: 0169-5002</identifier><identifier>EISSN: 1872-8332</identifier><identifier>DOI: 10.1016/0169-5002(95)00496-3</identifier><identifier>PMID: 8719064</identifier><identifier>CODEN: LUCAE5</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Aged ; Aged, 80 and over ; Biological and medical sciences ; Carcinoma, Non-Small-Cell Lung - epidemiology ; Carcinoma, Non-Small-Cell Lung - radiotherapy ; Carcinoma, Non-Small-Cell Lung - surgery ; Carcinoma, Non-Small-Cell Lung - therapy ; Confidence Intervals ; Cost ; Databases, Factual ; Economic analysis ; Female ; Humans ; Insurance, Health ; Lung cancer treatment ; Lung Neoplasms - epidemiology ; Lung Neoplasms - radiotherapy ; Lung Neoplasms - surgery ; Lung Neoplasms - therapy ; Male ; Medical sciences ; Medicare ; Morbidity ; Multivariate Analysis ; Odds Ratio ; Pneumology ; Practice variation ; Registries ; Retrospective Studies ; Socioeconomic Factors ; Socioeconomic status ; Thoracotomy ; Treatment Outcome ; Tumors of the respiratory system and mediastinum ; United States ; Virginia - epidemiology</subject><ispartof>Lung cancer (Amsterdam, Netherlands), 1995-12, Vol.13 (3), p.235-252</ispartof><rights>1995</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-988e0449c6d20c04b0fd180fde1e53ec6991c13771c1f511a8b4e836a7beefb03</citedby><cites>FETCH-LOGICAL-c386t-988e0449c6d20c04b0fd180fde1e53ec6991c13771c1f511a8b4e836a7beefb03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0169500295004963$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2947917$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8719064$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Smith, Thomas J.</creatorcontrib><creatorcontrib>Penberthy, Lynne</creatorcontrib><creatorcontrib>Desch, Christopher E.</creatorcontrib><creatorcontrib>Whittemore, Martha</creatorcontrib><creatorcontrib>Newschaffer, Craig</creatorcontrib><creatorcontrib>Hillner, Bruce E.</creatorcontrib><creatorcontrib>McClish, Donna</creatorcontrib><creatorcontrib>Retchin, Sheldon M.</creatorcontrib><title>Differences in initial treatment patterns and outcomes of lung cancer in the elderly</title><title>Lung cancer (Amsterdam, Netherlands)</title><addtitle>Lung Cancer</addtitle><description>Background: Non-small cell lung cancer (NSCLC) accounts for substantial deaths and costs in the elderly greater than 65 years old. The current practice of NSCLC treatment in a Medicare population was examined to ascertain important areas of practice variation, and differences in clinical outcome and costs. Methods: Data from incident cases of NSCLC from the Virginia Cancer Registry (VCR), 1985–1989, were matched with claims from Medicare Part A and B, census tract data and the Area Resource File. Multivariate models were created to include clinical data, demographics, and access information. Results: For patients with locoregional disease, increasing age was associated with lower likelihood of therapy (odds ratio (OR) 0.35; confidence intervals (CI) 0.29,0.43), thoracotomy (OR 0.27; CI 0.21,0.34), and more use of radiation therapy compared to surgery (OR 1.69; CI 1.39,2.03). Low education levels were associated with less likelihood of treatment (OR 0.78; CI 0.66,0.94), or radiation instead of surgery (OR 1.22; CI 1.05,1.47). Patients in urban areas were less likely to receive therapy (OR 0.67; CI 0.49,0.92). For distant disease, increasing age was also associated with lower likelihood of treatment (OR 0.48; CI 0.41,0.56), as was increasing co-morbidity (OR 0.84; CI 0.75,0.93). Distance to radiation oncologists made no difference in radiotherapy utilization. Two year survival according to therapy was surgery 66%, radiation 15%, no therapy 17%. Conclusions: Patterns of care, and survival according to therapy, vary widely for elderly NSCLC patients. Age, low education, higher co-morbidity and urban residence all decrease the likelihood of surgical therapy for locoregional NSCLC. Despite the availability of coverage through the Medicare program, use of therapies and survival is not uniform for all beneficiaries. Possible discrimination by age, co-morbid illnesses not recorded in the Medicare files, or patient and provider choice could all be involved; administrative billing files cannot resolve these important differences.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Non-Small-Cell Lung - epidemiology</subject><subject>Carcinoma, Non-Small-Cell Lung - radiotherapy</subject><subject>Carcinoma, Non-Small-Cell Lung - surgery</subject><subject>Carcinoma, Non-Small-Cell Lung - therapy</subject><subject>Confidence Intervals</subject><subject>Cost</subject><subject>Databases, Factual</subject><subject>Economic analysis</subject><subject>Female</subject><subject>Humans</subject><subject>Insurance, Health</subject><subject>Lung cancer treatment</subject><subject>Lung Neoplasms - epidemiology</subject><subject>Lung Neoplasms - radiotherapy</subject><subject>Lung Neoplasms - surgery</subject><subject>Lung Neoplasms - therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Medicare</subject><subject>Morbidity</subject><subject>Multivariate Analysis</subject><subject>Odds Ratio</subject><subject>Pneumology</subject><subject>Practice variation</subject><subject>Registries</subject><subject>Retrospective Studies</subject><subject>Socioeconomic Factors</subject><subject>Socioeconomic status</subject><subject>Thoracotomy</subject><subject>Treatment Outcome</subject><subject>Tumors of the respiratory system and mediastinum</subject><subject>United States</subject><subject>Virginia - epidemiology</subject><issn>0169-5002</issn><issn>1872-8332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1P3DAQhi1UtCxb_gFIOaCKHkLHcRLbF6QK2oKExGU5W44zpq7ysdgOEv8eh432WGlmfJjnHVkPIecUrinQ-kdqmVcAxZWsvgOUss7ZEVlTwYtcMFZ8IesDckJOQ_gHQDkFuSIrwamEulyT7Z2zFj0OBkPmhlQuOt1l0aOOPQ4x2-kY0Q8h00ObjVM0Y5_Q0WbdNLxkRqekn5PxL2bYtei796_k2Oou4Nnybsjz71_b2_v88enPw-3Px9wwUcdcCoFQltLUbQEGygZsS0UaSLFiaGopqaGM8zRtRakWTYmC1Zo3iLYBtiHf9nd3fnydMETVu2Cw6_SA4xQU50KAkCKB5R40fgzBo1U773rt3xUFNctUsyk1m1KyUp8yFUuxi-X-1PTYHkKLvbS_XPY6GN1Zn2S4cMAKWXJJecJu9hgmF28OvQrGzcZb59FE1Y7u___4AAjvkGE</recordid><startdate>19951201</startdate><enddate>19951201</enddate><creator>Smith, Thomas J.</creator><creator>Penberthy, Lynne</creator><creator>Desch, Christopher E.</creator><creator>Whittemore, Martha</creator><creator>Newschaffer, Craig</creator><creator>Hillner, Bruce E.</creator><creator>McClish, Donna</creator><creator>Retchin, Sheldon M.</creator><general>Elsevier Ireland Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19951201</creationdate><title>Differences in initial treatment patterns and outcomes of lung cancer in the elderly</title><author>Smith, Thomas J. ; Penberthy, Lynne ; Desch, Christopher E. ; Whittemore, Martha ; Newschaffer, Craig ; Hillner, Bruce E. ; McClish, Donna ; Retchin, Sheldon M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-988e0449c6d20c04b0fd180fde1e53ec6991c13771c1f511a8b4e836a7beefb03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Non-Small-Cell Lung - epidemiology</topic><topic>Carcinoma, Non-Small-Cell Lung - radiotherapy</topic><topic>Carcinoma, Non-Small-Cell Lung - surgery</topic><topic>Carcinoma, Non-Small-Cell Lung - therapy</topic><topic>Confidence Intervals</topic><topic>Cost</topic><topic>Databases, Factual</topic><topic>Economic analysis</topic><topic>Female</topic><topic>Humans</topic><topic>Insurance, Health</topic><topic>Lung cancer treatment</topic><topic>Lung Neoplasms - epidemiology</topic><topic>Lung Neoplasms - radiotherapy</topic><topic>Lung Neoplasms - surgery</topic><topic>Lung Neoplasms - therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Medicare</topic><topic>Morbidity</topic><topic>Multivariate Analysis</topic><topic>Odds Ratio</topic><topic>Pneumology</topic><topic>Practice variation</topic><topic>Registries</topic><topic>Retrospective Studies</topic><topic>Socioeconomic Factors</topic><topic>Socioeconomic status</topic><topic>Thoracotomy</topic><topic>Treatment Outcome</topic><topic>Tumors of the respiratory system and mediastinum</topic><topic>United States</topic><topic>Virginia - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Smith, Thomas J.</creatorcontrib><creatorcontrib>Penberthy, Lynne</creatorcontrib><creatorcontrib>Desch, Christopher E.</creatorcontrib><creatorcontrib>Whittemore, Martha</creatorcontrib><creatorcontrib>Newschaffer, Craig</creatorcontrib><creatorcontrib>Hillner, Bruce E.</creatorcontrib><creatorcontrib>McClish, Donna</creatorcontrib><creatorcontrib>Retchin, Sheldon M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Lung cancer (Amsterdam, Netherlands)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Smith, Thomas J.</au><au>Penberthy, Lynne</au><au>Desch, Christopher E.</au><au>Whittemore, Martha</au><au>Newschaffer, Craig</au><au>Hillner, Bruce E.</au><au>McClish, Donna</au><au>Retchin, Sheldon M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differences in initial treatment patterns and outcomes of lung cancer in the elderly</atitle><jtitle>Lung cancer (Amsterdam, Netherlands)</jtitle><addtitle>Lung Cancer</addtitle><date>1995-12-01</date><risdate>1995</risdate><volume>13</volume><issue>3</issue><spage>235</spage><epage>252</epage><pages>235-252</pages><issn>0169-5002</issn><eissn>1872-8332</eissn><coden>LUCAE5</coden><abstract>Background: Non-small cell lung cancer (NSCLC) accounts for substantial deaths and costs in the elderly greater than 65 years old. The current practice of NSCLC treatment in a Medicare population was examined to ascertain important areas of practice variation, and differences in clinical outcome and costs. Methods: Data from incident cases of NSCLC from the Virginia Cancer Registry (VCR), 1985–1989, were matched with claims from Medicare Part A and B, census tract data and the Area Resource File. Multivariate models were created to include clinical data, demographics, and access information. Results: For patients with locoregional disease, increasing age was associated with lower likelihood of therapy (odds ratio (OR) 0.35; confidence intervals (CI) 0.29,0.43), thoracotomy (OR 0.27; CI 0.21,0.34), and more use of radiation therapy compared to surgery (OR 1.69; CI 1.39,2.03). Low education levels were associated with less likelihood of treatment (OR 0.78; CI 0.66,0.94), or radiation instead of surgery (OR 1.22; CI 1.05,1.47). Patients in urban areas were less likely to receive therapy (OR 0.67; CI 0.49,0.92). For distant disease, increasing age was also associated with lower likelihood of treatment (OR 0.48; CI 0.41,0.56), as was increasing co-morbidity (OR 0.84; CI 0.75,0.93). Distance to radiation oncologists made no difference in radiotherapy utilization. Two year survival according to therapy was surgery 66%, radiation 15%, no therapy 17%. Conclusions: Patterns of care, and survival according to therapy, vary widely for elderly NSCLC patients. Age, low education, higher co-morbidity and urban residence all decrease the likelihood of surgical therapy for locoregional NSCLC. Despite the availability of coverage through the Medicare program, use of therapies and survival is not uniform for all beneficiaries. Possible discrimination by age, co-morbid illnesses not recorded in the Medicare files, or patient and provider choice could all be involved; administrative billing files cannot resolve these important differences.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>8719064</pmid><doi>10.1016/0169-5002(95)00496-3</doi><tpages>18</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0169-5002
ispartof Lung cancer (Amsterdam, Netherlands), 1995-12, Vol.13 (3), p.235-252
issn 0169-5002
1872-8332
language eng
recordid cdi_proquest_miscellaneous_77880898
source MEDLINE; Elsevier ScienceDirect Journals
subjects Aged
Aged, 80 and over
Biological and medical sciences
Carcinoma, Non-Small-Cell Lung - epidemiology
Carcinoma, Non-Small-Cell Lung - radiotherapy
Carcinoma, Non-Small-Cell Lung - surgery
Carcinoma, Non-Small-Cell Lung - therapy
Confidence Intervals
Cost
Databases, Factual
Economic analysis
Female
Humans
Insurance, Health
Lung cancer treatment
Lung Neoplasms - epidemiology
Lung Neoplasms - radiotherapy
Lung Neoplasms - surgery
Lung Neoplasms - therapy
Male
Medical sciences
Medicare
Morbidity
Multivariate Analysis
Odds Ratio
Pneumology
Practice variation
Registries
Retrospective Studies
Socioeconomic Factors
Socioeconomic status
Thoracotomy
Treatment Outcome
Tumors of the respiratory system and mediastinum
United States
Virginia - epidemiology
title Differences in initial treatment patterns and outcomes of lung cancer in the elderly
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T09%3A51%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differences%20in%20initial%20treatment%20patterns%20and%20outcomes%20of%20lung%20cancer%20in%20the%20elderly&rft.jtitle=Lung%20cancer%20(Amsterdam,%20Netherlands)&rft.au=Smith,%20Thomas%20J.&rft.date=1995-12-01&rft.volume=13&rft.issue=3&rft.spage=235&rft.epage=252&rft.pages=235-252&rft.issn=0169-5002&rft.eissn=1872-8332&rft.coden=LUCAE5&rft_id=info:doi/10.1016/0169-5002(95)00496-3&rft_dat=%3Cproquest_cross%3E77880898%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77880898&rft_id=info:pmid/8719064&rft_els_id=0169500295004963&rfr_iscdi=true